{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:19:33Z","timestamp":1791422373173,"version":"4.3.3"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T00:00:00Z","timestamp":1179792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,22]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Cytomegalovirus (CMV) is the leading cause of congenital viral infection, with an incidence of 0\u00b75\u20133% of live births worldwide. Clinical evidence has shown hearing and vision loss, mental retardation and sometimes death in affected newborns. Primary maternal CMV infection during gestation poses a 40% risk of intrauterine transmission in contrast to recurrent infection. European laboratories have made significant progress in the last decade in solving diagnostic problems linked to infection in pregnancy. With the advances in CMV serology, such as detection of anti-CMV IgM by enzyme immunoassays (EIA), confirmed by Western blot, together with seroconversion and anti-CMV IgG avidity evaluation in pregnant mothers, can help to identify recent infection. Preventative measures such as screening for CMV in the routine serological work-up of pregnant women have been introduced in countries such as Spain and Italy. The development of specific T cell-mediated immune responses in mothers, fetus and neonates is now emerging with regard to antigen-specific CD4 and CD8 T cells, differentiation status, proliferative and cytokine responses. A protective vaccine against CMV is a major public health priority and the study of vaccines in animal model systems has identified potential strategies for interrupting transmission and preventing disease in newborns. Congenital CMV infection has a variable outcome and therefore novel diagnostic methods are required to identify those at risk and therapeutic interventions are needed to improve the long-term prognosis of those infected. CMV was first isolated in 1957. We are now 50\u2003years on, so procrastination is not an option.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2007.03454.x","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T21:27:50Z","timestamp":1255469270000},"page":"205-210","source":"Crossref","is-referenced-by-count":31,"title":["Translational Mini-Review Series on Infectious Disease:&amp;#x2028;Congenital cytomegalovirus infection: 50\u2003years on"],"prefix":"10.1093","volume":"149","author":[{"given":"J","family":"Hassan","sequence":"first","affiliation":[{"name":"National Virus Reference Laboratory and Centre for Research into Infectious Disease, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Connell","sequence":"additional","affiliation":[{"name":"National Virus Reference Laboratory and Centre for Research into Infectious Disease, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,7,14]]},"reference":[{"key":"2022010406291197200_b1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/00379727-94-22841","article-title":"Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease","volume":"94","author":"Craig","year":"1957","journal-title":"Proc Sov Exp Biol Med"},{"key":"2022010406291197200_b2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/siny.2002.0123","article-title":"Strategies to prevent CMV infection in the neonate","volume":"7","author":"Griffiths","year":"2002","journal-title":"Semin Neonatol"},{"key":"2022010406291197200_b3","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"key":"2022010406291197200_b4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","article-title":"Genetic content of wild-type human cytomegalovirus","volume":"85","author":"Dolan","year":"2004","journal-title":"J Gen Virol"},{"key":"2022010406291197200_b5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"2022010406291197200_b6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1086\/340653","article-title":"Cytomegalovirus replication dynamics in immunologically naive and experienced immunocompromised hosts","volume":"185","author":"Emery","year":"2002","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00002030-199307000-00010","article-title":"A clinico-pathological audit of opportunistic viral infections in HIV-infected patients","volume":"7","author":"Pillay","year":"1993","journal-title":"AIDS"},{"key":"2022010406291197200_b8","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1128\/jvi.70.5.3215-3226.1996","article-title":"Developmental analysis of the cytomegalovirus enhancer in transgenic animals","volume":"70","author":"Baskar","year":"1996","journal-title":"J Virol"},{"key":"2022010406291197200_b9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/rmv.315","article-title":"A review of genetic differences between limited and extensively passaged human cytomegalovirus strains","volume":"11","author":"Prichard","year":"2001","journal-title":"Rev Med Virol"},{"key":"2022010406291197200_b10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/0022-1317-76-4-741","article-title":"Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues","volume":"76","author":"Sinzger","year":"1995","journal-title":"J Gen Virol"},{"key":"2022010406291197200_b11","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.78.8.5104","article-title":"Increased susceptibility to cytomegalovirus infection in beige mutant mice","volume":"78","author":"Shellam","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010406291197200_b12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-3083.1985.tb01867.x","article-title":"The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice","volume":"22","author":"Shellam","year":"1985","journal-title":"Scand J Immunol"},{"key":"2022010406291197200_b13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/B978-0-12-647680-4.50037-X","volume-title":"Genetic control of natural resistance to infection and malignancy","author":"Bancroft","year":"1980"},{"key":"2022010406291197200_b14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.126.3.988","article-title":"Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance","volume":"126","author":"Bancroft","year":"1981","journal-title":"J Immunol"},{"key":"2022010406291197200_b15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/jvi.52.1.119-128.1984","article-title":"Pathogenesis of murine cytomegalovirus infection in natural killer cell depleted mice","volume":"52","author":"Bukowski","year":"1984","journal-title":"J Virol"},{"key":"2022010406291197200_b16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1099\/0022-1317-61-1-133","article-title":"Effect of Nu\/Nu gene on genetically determined resistance to murine cytomegalovirus","volume":"61","author":"Grundy","year":"1982","journal-title":"J Gen Virol"},{"key":"2022010406291197200_b17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/iai.37.1.143-150.1982","article-title":"Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes","volume":"37","author":"Grundy","year":"1982","journal-title":"Infect Immun"},{"key":"2022010406291197200_b18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med"},{"key":"2022010406291197200_b19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.vaccine.2004.06.038","article-title":"Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV sero-negative subjects","volume":"23","author":"Schleiss","year":"2004","journal-title":"Vaccine"},{"key":"2022010406291197200_b20","first-page":"12","article-title":"Immunosuppressive effects of \u03b2-herpesviruses","volume":"10","author":"Boeckh","year":"2003","journal-title":"Herpes"},{"key":"2022010406291197200_b21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/314428","article-title":"Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients","volume":"178","author":"Schoppel","year":"1998","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(86)92298-1","article-title":"Reinfection of a seropositive allograft recipient by cytomegalovirus from donor kidney","volume":"i","author":"Grundy","year":"1986","journal-title":"Lancet"},{"key":"2022010406291197200_b23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/iai.17.2.458-462.1977","article-title":"Role of T lymphocytes in recovery","volume":"17","author":"Starr","year":"1977","journal-title":"Infect Immun"},{"key":"2022010406291197200_b24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nri932","article-title":"Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance","volume":"2","author":"Reddehase","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2022010406291197200_b25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0966-842X(02)02393-4","article-title":"Immunomodulation by cytomegalovirus: manipulation strategies beyond evasion","volume":"10","author":"Mocarski","year":"2002","journal-title":"Trend Microbiol"},{"key":"2022010406291197200_b26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"2022010406291197200_b27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"2022010406291197200_b28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/iai.27.3.767-776.1980","article-title":"Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus","volume":"27","author":"Ho","year":"1980","journal-title":"Infect Immun"},{"key":"2022010406291197200_b29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1099\/0022-1317-47-2-503","article-title":"Role of cytotoxic T lymphocytes in murine cytomegalovirus","volume":"47","author":"Quinnan","year":"1980","journal-title":"J Gen Virol"},{"key":"2022010406291197200_b30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01317494","article-title":"Induction of virus specific and H-2 restricted cytotoxic T cells by UV inactivated murine cytomegalovirus","volume":"60","author":"Sethi","year":"1979","journal-title":"Arch Virol"},{"key":"2022010406291197200_b31","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.4049\/jimmunol.173.12.7481","article-title":"Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection","volume":"173","author":"Khan","year":"2004","journal-title":"J Immunol"},{"key":"2022010406291197200_b32","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/340637","article-title":"Cytomegalovirus (CMV) phophoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals","volume":"185","author":"Kern","year":"2002","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b33","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2002-08-2502","article-title":"Primary immune responses to human CMV. a critical role for IFN-\u03b3-producing CD4+ T cells in protection against CMV disease","volume":"101","author":"Gamadia","year":"2003","journal-title":"Blood"},{"key":"2022010406291197200_b34","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.172.5.3260","article-title":"Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children","volume":"172","author":"Tu","year":"2004","journal-title":"J Immunol"},{"key":"2022010406291197200_b35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2249.2007.03302.x","article-title":"Immunological response to cytomegalovirus in congenitally infected neonates","volume":"147","author":"Hassan","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2022010406291197200_b36","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI200317470","article-title":"Mature CD8+ T lymphocyte response to viral infection during fetal life","volume":"111","author":"Marchant","year":"2003","journal-title":"J Clin Invest"},{"key":"2022010406291197200_b37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0163-7258(03)00034-2","article-title":"The human cytomegalovirus","volume":"98","author":"Landolfo","year":"2003","journal-title":"Pharmacol Therapeut"},{"key":"2022010406291197200_b38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-291X(90)90903-Z","article-title":"Human cytomegalovirus stimulates arachadonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C","volume":"166","author":"AbuBakar","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2022010406291197200_b39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0966-842X(00)01699-1","article-title":"Exploitation of cellular signalling and regulatory pathways by human cytomegalovirus","volume":"8","author":"Fortunato","year":"2000","journal-title":"Trends Microbiol"},{"key":"2022010406291197200_b40","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1128\/jvi.69.9.5391-5400.1995","article-title":"Human cytomegalovirus upregulates NF-\u03baB activity by transactivating the NF-\u03baB p105\/p50 and p65 promoters","volume":"69","author":"Yurochko","year":"1995","journal-title":"J Virol"},{"key":"2022010406291197200_b41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1084\/jem.187.5.675","article-title":"Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak\/Stat pathway","volume":"187","author":"Miller","year":"1998","journal-title":"J Exp Med"},{"key":"2022010406291197200_b42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.1999.tb01291.x","article-title":"Cytomegaloviral control of MHC class I function in the mouse","volume":"168","author":"Hengel","year":"1999","journal-title":"Immunol Rev"},{"key":"2022010406291197200_b43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/383720a0","article-title":"Cytomegalovirus selectivity blocks antigen processing and presentation of its immediate-early gene product","volume":"383","author":"Gilbert","year":"1996","journal-title":"Nature"},{"key":"2022010406291197200_b44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.280.5361.248","article-title":"Viral strategies of immune evasion","volume":"280","author":"Ploegh","year":"1998","journal-title":"Science"},{"key":"2022010406291197200_b45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1074-7613(00)80349-0","article-title":"The ER-luminal domain of the HCMV glycoprotein US6 inhibitis peptide translocation by TAP","volume":"6","author":"Ahn","year":"1997","journal-title":"Immunity"},{"key":"2022010406291197200_b46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","article-title":"ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor","volume":"14","author":"Cosman","year":"2001","journal-title":"Immunity"},{"key":"2022010406291197200_b47","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.162.12.6967","article-title":"Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus","volume":"162","author":"Benedict","year":"1999","journal-title":"J Immunol"},{"key":"2022010406291197200_b48","doi-asserted-by":"crossref","first-page":"9839","DOI":"10.1073\/pnas.96.17.9839","article-title":"Cytomegalovirus encodes a potent alpha chemokine","volume":"96","author":"Penfold","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010406291197200_b49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-5793(98)01551-8","article-title":"Selective recognition of the membrane bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28","volume":"441","author":"Kledal","year":"1998","journal-title":"FEBS Lett"},{"key":"2022010406291197200_b50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(93)90118-A","article-title":"Molecular cloning, functional expression, and signalling characteristics of a C-C chemokine receptor","volume":"72","author":"Neote","year":"1993","journal-title":"Cell"},{"key":"2022010406291197200_b51","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1073\/pnas.121177598","article-title":"Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B","volume":"98","author":"Simmen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010406291197200_b52","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1073\/pnas.95.24.14470","article-title":"Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotides arrays","volume":"95","author":"Zhu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010406291197200_b53","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J Virol"},{"key":"2022010406291197200_b54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Ann Rev Immunol"},{"key":"2022010406291197200_b55","first-page":"405","article-title":"Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus","volume":"78","author":"Grundy","year":"1993","journal-title":"Immunology"},{"key":"2022010406291197200_b56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007890-199901150-00023","article-title":"Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins","volume":"67","author":"Burns","year":"1999","journal-title":"Transplantation"},{"key":"2022010406291197200_b57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)92997-3","article-title":"Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero","volume":"1","author":"Elek","year":"1974","journal-title":"Lancet"},{"key":"2022010406291197200_b58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-114-7-525","article-title":"Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial","volume":"114","author":"Plotkin","year":"1991","journal-title":"Ann Intern Med"},{"key":"2022010406291197200_b59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b60","first-page":"121","article-title":"Vaccination against cytomegalovirus","author":"Plotkin","year":"2001","journal-title":"Arch Virol"},{"key":"2022010406291197200_b61","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/172.5.1212","article-title":"Reduced congenital cytomegalovirus infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model","volume":"192","author":"Harrison","year":"1995","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b62","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320714","article-title":"Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein B antibody transfer in guinea pigs","volume":"183","author":"Chatterjee","year":"2001","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b63","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"Pass","year":"1999","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b64","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/314951","article-title":"A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)","volume":"180","author":"Adler","year":"1999","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molmed.2005.11.006","article-title":"Human cytomegalovirus vaccine: time to look for alternative options","volume":"12","author":"Khanna","year":"2006","journal-title":"Trends Mol Med"},{"key":"2022010406291197200_b66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1086\/505427","article-title":"Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection","volume":"194","author":"Arav-Boger","year":"2006","journal-title":"J Infect Dis"},{"key":"2022010406291197200_b67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/rmv.517","article-title":"Diagnosis of congenital CMV infection via dried blood spots","volume":"16","author":"Barbi","year":"2006","journal-title":"Rev Med Virol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2007.03454.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/149\/2\/205\/42037069\/j.1365-2249.2007.03454.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/149\/2\/205\/42037069\/j.1365-2249.2007.03454.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T04:41:50Z","timestamp":1685162510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/149\/2\/205\/6457741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,22]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,7,14]]},"published-print":{"date-parts":[[2007,5,22]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03454.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,8]]},"published":{"date-parts":[[2007,5,22]]}}}